Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines

Lupus

Volumn 22, Issue 3, 2013, Pages 262-267

  Navarra, S V ^a   Tanangunan, Rmdv ^a   Mikolaitis Preuss, R A ^b   Kosinski, M ^c   Block, J A ^b   Jolly, M ^b  

^a UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c QualityMetric   (United States)

Author keywords

patient reported outcomes; Philippines; quality of life; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; HYDROXYCHLOROQUINE; PREDNISONE;

ADULT; ARTICLE; DEMOGRAPHY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHILIPPINES; PRIORITY JOURNAL; SHORT FORM 36; SYSTEMIC LUPUS ERYTHEMATOSUS; TEST RETEST RELIABILITY; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; CROSS-CULTURAL COMPARISON; CULTURAL CHARACTERISTICS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHILIPPINES; PSYCHOMETRICS; SELF REPORT; YOUNG ADULT;

EID: 84874434573     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312474086     Document Type: Article

References (22)

1. Jolly M, Utset TO. Health related quality of life among outpatient systemic lupus erythematosus University of Chicago cohort. Arthritis Rheum. 2003 ; 48: 3642-3642
2. Jolly M, Pickard SA, Mikolaitis RA, Rodby RA, Sequeira W, Block JA. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J Rheumatol. 2010 ; 37: 1828-1833
3. Jolly M, Utset TO. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life?. Lupus. 2004 ; 13: 924-926
4. Moldovan I, Katsaros E, Carr FN, Cooray D, Torralba K, et al. The Patient Reported Outcomes in Lupus (PATROL) study: Role of depression in health-related quality of life in a Southern California lupus cohort. Lupus. 2011 ; 20: 1285-1292
5. Hyphantis T, Palieraki K, Voulgari PV, Tsifetaki N, Drosos AA. Coping with health-stressors and defence styles associated with health-related quality of life in patients with systemic lupus erythematosus. Lupus. 2011 ; 20: 893-903
6. Gallop K, Nixon A, Swinburn P, Sterling K, Naegeli A, Silk M. Development of a conceptual model of health-related quality of life for systemic lupus erythematosus from the patient's perspective. Lupus. 2012 ; 21: 934-943
7. Thumboo J, Fong KY. Health-related quality of life of patients with systemic lupus erythematosus in Asia: How can this be improved?. Lupus. 2010 ; 19: 1430-1435
8. Alarcón GS, McGwin G, Brooks K, et al. Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: A comparison of physician and patient visual analog scale scores. Arthritis Rheum. 2002 ; 47: 408-413
9. Food and Drug Administration. Guidance for industry on patient-reported outcome measures: Use in medical product development to support labeling claims, http://www.fda.gov/ohrms/dockets/98fr/06d-0044-gdl0001.pdf (2006, accessed 23.03.2012).
10. Jolly M, Pickard AS, Block JA, et al. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum. 2012 ; 42: 56-65
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
12. Ware JE Quality of life and pharmacoeconomics in clinical trials. 36 Health Survey. In: SpikerB (ed.) Quality of life and pharmacoeconomics in clinical trials. 2nd edn. Philadelphia: Lippincott-Raven, pp. 337-345, 1996. Spiker B, ed. Philadelphia: Lippincott-Raven ; 1996: 337-345.
13. EuroQoL Group. EuroQoL - a new facility for the measurement of health related quality of life. Health Policy. 1990 ; 16: 199-208
14. Aggarwal R, Wilke CT, Pickard AS, et al. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol. 2009 ; 36: 1209-1216
15. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005 ; 353: 2550-2558
16. Ruperto N, Hanrahan LM, Alarcón GS, et al. International consensus for a definition of disease flare in lupus. Lupus. 2011 ; 20: 453-462
17. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
18. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res. 1993 ; 2: 441-449
19. Thakkar A, Mikolaitis RA, Block JA, Jolly M. Caregiver burden is associated with worse dyadic relationship and health outcomes in lupus?. Arthritis Rheum Suppl. 2011 ; 63: 1422-1422
20. Mplus User's Guide. Version 1. Los Angeles: Muthén & Muthén, 1998.
21. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Modeling. 1999 ; 6: 1-55
22. Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?. J Rheumatology. 2005 ; 32: 1706-1708